Concurrent Chemoradiotherapy Followed by Metastasectomy Converts to Survival Benefit in Stage IV Rectum Cancer
Journal of Gastrointestinal Surgery, 08/10/2012
Lin JK et al. – Upfront concurrent chemoradiotherapy (CCRT) only provided a survival benefit in patients with stage IV rectum cancer who undergo subsequent metastasectomy.



